Robin: A multi-agent system for automating scientific discovery

AI-generated keywords: Scientific discovery

AI-generated Key Points

  • Scientific discovery involves background research, hypothesis generation, experimentation, and data analysis.
  • Artificial intelligence has been increasingly used in scientific discovery but no system has fully automated all stages until now.
  • Robin is the first multi-agent system capable of autonomously conducting key intellectual steps of the scientific process.
  • Robin integrates literature search agents with data analysis agents to generate hypotheses, propose experiments, interpret results, and update hypotheses semi-autonomously.
  • In a recent study focused on dAMD, Robin identified a novel treatment strategy by enhancing retinal pigment epithelium phagocytosis using ripasudil as a therapeutic candidate.
  • Robin suggested and analyzed an RNA-seq experiment to understand how ripasudil upregulates phagocytosis by revealing the upregulation of ABCA1 as a potential new target.
  • Robin can generate therapeutic candidates for experimental testing by querying Falcon based on scientific rationale and pharmacological profile.
Also access our AI generated: Comprehensive summary, Lay summary, Blog-like article; or ask questions about this paper to our AI assistant.

Authors: Ali Essam Ghareeb, Benjamin Chang, Ludovico Mitchener, Angela Yiu, Caralyn J. Szostkiewicz, Jon M. Laurent, Muhammed T. Razzak, Andrew D. White, Michaela M. Hinks, Samuel G. Rodriques

License: CC BY 4.0

Abstract: Scientific discovery is driven by the iterative process of background research, hypothesis generation, experimentation, and data analysis. Despite recent advancements in applying artificial intelligence to scientific discovery, no system has yet automated all of these stages in a single workflow. Here, we introduce Robin, the first multi-agent system capable of fully automating the key intellectual steps of the scientific process. By integrating literature search agents with data analysis agents, Robin can generate hypotheses, propose experiments, interpret experimental results, and generate updated hypotheses, achieving a semi-autonomous approach to scientific discovery. By applying this system, we were able to identify a novel treatment for dry age-related macular degeneration (dAMD), the major cause of blindness in the developed world. Robin proposed enhancing retinal pigment epithelium phagocytosis as a therapeutic strategy, and identified and validated a promising therapeutic candidate, ripasudil. Ripasudil is a clinically-used rho kinase (ROCK) inhibitor that has never previously been proposed for treating dAMD. To elucidate the mechanism of ripasudil-induced upregulation of phagocytosis, Robin then proposed and analyzed a follow-up RNA-seq experiment, which revealed upregulation of ABCA1, a critical lipid efflux pump and possible novel target. All hypotheses, experimental plans, data analyses, and data figures in the main text of this report were produced by Robin. As the first AI system to autonomously discover and validate a novel therapeutic candidate within an iterative lab-in-the-loop framework, Robin establishes a new paradigm for AI-driven scientific discovery.

Submitted to arXiv on 19 May. 2025

Ask questions about this paper to our AI assistant

You can also chat with multiple papers at once here.

AI assistant instructions?

Results of the summarizing process for the arXiv paper: 2505.13400v1

Scientific discovery is a complex process that involves background research, hypothesis generation, experimentation, and data analysis. While artificial intelligence has been increasingly used in scientific discovery, no system has fully automated all these stages in a single workflow until now. Introducing Robin, the first multi-agent system capable of autonomously conducting key intellectual steps of the scientific process. By integrating literature search agents with data analysis agents, Robin can generate hypotheses, propose experiments, interpret results, and update hypotheses in a semi-autonomous manner. In a recent study focused on , Robin identified a novel treatment strategy by enhancing retinal pigment epithelium phagocytosis. Through its autonomous processes, Robin proposed and validated ripasudil as a promising therapeutic candidate for dAMD. Ripasudil is a rho kinase (ROCK) inhibitor that had not previously been considered for treating dAMD. To further understand how ripasudil upregulates phagocytosis, Robin suggested and analyzed an RNA-seq experiment which revealed the upregulation of ABCA1, a critical lipid efflux pump and potential new target. Expanding on its capabilities, Robin can also generate therapeutic candidates for experimental testing by querying Falcon to evaluate each candidate based on scientific rationale and pharmacological profile. The ranked list of drug candidates can then be reviewed by human scientists for further testing in the lab. Overall, Robin represents a groundbreaking advancement in AI-driven scientific discovery by autonomously identifying and validating novel therapeutic candidates within an iterative lab-in-the-loop framework. Its ability to seamlessly integrate literature search with data analysis sets a new standard for AI-driven scientific research and opens up exciting possibilities for accelerating the pace of scientific discovery.
Created on 07 Jul. 2025

Assess the quality of the AI-generated content by voting

Score: 0

Why do we need votes?

Votes are used to determine whether we need to re-run our summarizing tools. If the count reaches -10, our tools can be restarted.

Similar papers summarized with our AI tools

Navigate through even more similar papers through a

tree representation

Look for similar papers (in beta version)

By clicking on the button above, our algorithm will scan all papers in our database to find the closest based on the contents of the full papers and not just on metadata. Please note that it only works for papers that we have generated summaries for and you can rerun it from time to time to get a more accurate result while our database grows.

Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.